PracaRelacje InwestorskieCOVID-19
  1. Siemens Healthineers Polska
  2. Healthcare IT
  3. Rozwiązania informatyczne w diagnostyce
  4. AI-Pathway Companion

AI-Pathway Companion*Optimizing care pathways with the AI-Pathway Companion

Our vision*

To optimize care pathways with an intelligent decision support system aimed at facilitating diagnosis and therapeutic decisions along disease-specific pathways.


As today’s healthcare delivery system continues to accelerate and evolve key stakeholders from hospital executives to clinicians, are faced with a growing number of challenges in the enabling and sustaining of outcomes-based healthcare. Data overload, interoperability, physician burnout, and overall rising cost of care serve as barriers in the disruption of precise diagnosis, prognosis, and treatment-driven patient outcomes. 

Diagnostic accuracy

  • $585 Bn. wasted on error-prone and inefficiently delivered services1
  • 38.2% The most common cited reasons for overtreatment were difficulty accessing medical records2
Diagnostic Accuracy

Data integration

  • 50% of patients report that information necessary to their care was not available when needed1
  • 73 days in 2010 it took 3.5 years for medical data to double. In 2020 it is projected to be 0.2 years – just 73 days3
Data Integration

Product vision*

Keeping patients at the center of it all

Keeping patients at the center of it all

AI-Pathway Companion product features

Leveraging data integration and artificial intelligence technology, the solution AI-Pathway Companion with its applications aims to support your multidisciplinary physician team to ease diagnosis and treatment decisions. AI-Pathway Companion may enable personalized and standardized patient management and plans to offer process improvement insights through analysis of key performance indicators. The AI-Pathway Companion product suite could help you to make patient-centric diagnosis and treatment decisions along disease-specific care pathways using augmented intelligence, data integration, and insights from cohort analytics.

Our goals for the AI-Pathway Companion product suite:

  • AI-Pathway Companion enables automatic patient-specific mapping along the clinical pathway using evidence-based guidelines4-7
  • AI-Pathway Companion facilitates objective decision-making by multi-disciplinary experts on correlated patient data and preferences4
  • AI-Pathway Companion offers transparent insights into time to diagnosis and treatment4
  • AI-Pathway Companion provides process improvement insights through cohort analysis of performance indicators8

 

Envisioned benefits*

Future Outlook AI-Pathway Companion
* AI-Pathway Companion is currently under development. It is not for sale and its future availability cannot be guaranteed. AI-Pathway Companion Prostate Cancer does not yet fulfil all the essential requirements according to the European Medical Device Directive (93/42/EEC) and its national implementations.
1
Institute of Medicine. 2013. Best Care at Lower Cost: The Path to Continuously Learning Health Care in America. Washington, DC: The National Academies Press.
2
Overtreatment in the United States, 2017 lyu et al.
3
University of Iowa, Carver College of Medicine report, 2014.
4
This function is supported by AI-Pathway Companion Prostate Cancer.
5
Prerequisite: “All data is available as required per guideline.”; Feature dependent on quality of input data.
6
AI-Pathway Companion Prostate Cancer VA10A supports prostate cancer adenocarcinoma cases only.
7
AI-Pathway Companion Prostate Cancer VA10A supports NCCN guidelines. EAU guideline support under development.
8
This function is supported by AI-Pathway Companion Analytics.
9
This function is supported by AI-Pathway Companion Connector.